Increased Expression of Costimulatory Molecules on Peripheral Blood Monocytes in Patients with Crohn's Disease

References

• MacDermott R. P., Stenson W. F. Alterations of the immune system in ulccrative colitis and Crohn's disease. Adv Immunol 1988; 42: 285–328
   PubMed Web of Science ®Google Scholar
• Schreiber S., Raedler A., Stenson W. F., MacDermott R. P. The role of the mucosal immune system in inflammatory bowel disease. Gastroenterol Clin North Am 1992; 21: 451–502
   PubMed Web of Science ®Google Scholar
• Mueller C. H., Knoflash P., Zielinski C. C. T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and in supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990; 98: 639–46
   PubMed Web of Science ®Google Scholar
• Pallone F., Fuis S., Squarcia O., Bianocc L., Pozzilli P., Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined as by the expression of early activation antigens. Gut 1987; 28: 745–53
   PubMed Web of Science ®Google Scholar
• Roman L. I., Manzano L., Hera A., Abreu L., Rossi I., Alvarez-Mon M. Expanded CD4+ CD45RO+ phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroentcrology 1996; 110: 1008–19
   PubMed Web of Science ®Google Scholar
• Liu Z. X., Noguchi M., Hiwatashi N., Toyoda T. Monocyte aggregation and multinucleated giant-cell formation in vitro in Crohn's disease. The effect of cell adhesion molecules. Scand J Gastroenterol 1996; 31: 706–10
   PubMed Web of Science ®Google Scholar
• Baldassano R. N., Schreiber S., Johnston R. B., Fu R. D., Muraki T., MacDermott R. P. Crohn's disease monocytes are primed for accentuated release of toxic oxygen metabolites. Gastroenterology 1993; 105: 60–6
   PubMed Web of Science ®Google Scholar
• Burgio V. E., Fais S., Boirivant M., Perrone A., Pallone F. Peripheral monocytes and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995; 109: 1029–38
   PubMed Web of Science ®Google Scholar
• Van Seventer G. A., Shimizu Y., Shaw S. Roles of multiple accessary molecules in T cell activation. Curr Opin Immunol 1991; 3: 361–72
   PubMed Web of Science ®Google Scholar
• Allison J. P. CD28-B7 interaction in T-cell activation. Curr Opin Immunol 1994; 6: 414–9
   PubMed Web of Science ®Google Scholar
• June C. H., Bluestone J. A., Nudler C. M., Tompson C. The B7 and CD28 receptor families. Immunol Today 1994; 15: 321–31
   PubMedGoogle Scholar
• Best W. R., Becktel J. M., Singelton J. W., Kern F., Jr. Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976; 70: 439–44
   PubMed Web of Science ®Google Scholar
• Truelove S. C., Witts L. J. Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 1955; 2: 1041–8
   PubMed Web of Science ®Google Scholar
• Selby W. S., Jewell D. P. T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut 1983; 24: 99–106
   PubMed Web of Science ®Google Scholar
• Senju M., Hulstaert F., Jewell D. P. Flow cytometric analysis of peripheral blood lymphocytes in ulcerative colitis and Crohn's disease. Gut 1991; 32: 779–83
   PubMed Web of Science ®Google Scholar
• Chaux P., Moutet M., Faivre J., Martin F., Martin M. Inflammatory cells infiltrating human colorectal carcinomas express HLá class II but not B7–1 and B7–2 costimulatory molecules of the T-cell activation. Lab Invest 1996; 74: 975–83
   PubMed Web of Science ®Google Scholar
• Springer T. A. Adhesion receptors of immune system. Nature 1990; 346: 425–33
   PubMed Web of Science ®Google Scholar
• Dubey C., Croft M., Swain S. L. Costimulatory requirements of naive CD4+ T cells. ICAM-1 or B7–1 can costimulate naive CD4 T cell activation but are required for optium response. J Immunol 1995; 155: 45–57
   PubMed Web of Science ®Google Scholar
• Van Seventer G. A., Shimizu Y., Morgan K. J., Shaw S. The LFA-1 ligand ICAM-1 provides an important costimulating signal for T cell receptor-mediated activation of resting T cells. J Immunol 1990; 144: 4579–86
   PubMed Web of Science ®Google Scholar
• Mallizia G., Calabrese A., Cottone M., Ramondo M., Trejdosiewie Z. L., Smart J., et al. Expression of leukocyte adhesion molecules by mononuclear phagocytes in inflammatory bowel disease. Gastroenterology 1991; 100: 150–9
   PubMed Web of Science ®Google Scholar
• Jones S. C., Banks R. E., Haidar A., Gearing A. J H, Hemingway I. K., Ibbotson S. H., et al. Adhesion molecules in inflammatory bowel disease. Gut 1995; 36: 724–30
   PubMed Web of Science ®Google Scholar
• Greenfield S. M., Hamblin A., Punchard N. A., Thompson R. P H. Expression of adhesion molecules on circulating leukocytes in patients with inflammatory bowel disease. Clin Sci 1992; 83: 221–6
   Web of Science ®Google Scholar
• Collins C. E., Davies C., Macey M. G., McCarthy D. A., Rampton D. S. Increased expression of circulating leukocyte adhesion molecules CD11b and CD 18 in inflammatory bowel disease. Gastroenterology 1996; 110: A885
   PubMed Web of Science ®Google Scholar
• Gardiner K. R., Crockard A. D., Halliday M. I., Rowlands B. J. Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease. Gut 1994; 35: 511–6
   PubMed Web of Science ®Google Scholar
• Ayala A., Perrin M. M., Chaudry I. H. Defective macrophage antigen presentation following hemorrhage is associated with the loss of MHC class II (Ta) antigens. Immunology 1990; 70: 33–9
   PubMed Web of Science ®Google Scholar
• Mullin G., Lazenby A. J., Harris M. L., Bayless T. M., James S. P. Increased interleukin 2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitis. Gastroenterology 1992; 102: 1620–7
   PubMed Web of Science ®Google Scholar
• MacDonald T. T., Hutchings P., Choy M. Y., Murch S., Cooke A. Tumor necrosis factor-alpha and interferon-gamma production measured at the single cell level in normal and inflamed human intestine. Clin Exp Immunol 1990; 81: 301–5
   PubMed Web of Science ®Google Scholar
• Fuss I. J., Neurath M., Boirivant M., Klein J. S., Motte C. D L, Strong S. A., et al. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. J Immunol 1996; 157: 1261–70
   PubMed Web of Science ®Google Scholar
• Bouma G., Oudkerk Pool M., Scharenberg J. G M, Kolkman J. J., Von Blomberg B. M E, Scheper R. J., et al. Differences in the intrinsic capacity of peripheral blood mononuclear cells to produce tumor necrosis factor alpha and beta in patients with inflammatory bowel disease and healthy controls. Scand J Gastroenterol 1996; 30: 1095–100
   Web of Science ®Google Scholar